SGLT2i Tied to Fewer Post-MI Deaths in T2D SGLT2i Tied to Fewer Post-MI Deaths in T2D

Observational registry data from Sweden showed a significant link between SGLT2 inhibitor use at the time of an MI in people with type 2 diabetes and fewer all-cause deaths in 1-year follow-up.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Cardiology News Source Type: news